The latest health and social care news and a look at research and development into the treatment of common and rare diseases alike. We also look at the vital changes being made to help deliver effective healthcare through the digital transformation within the NHS.
A dangerous hospital superbug, Pseudomonas aeruginosa, can now digest medical plastic like sutures and implants, microbiologists reveal. This alarming ability allows the pathogen to survive longer and form tougher antibiotic-resistant biofilms, posing a significant new threat to patient safety in healthcare settings.
The US Food and Drug Administration (FDA) have approved a third Pfizer dose for people who are immunocompromised - despite the WHO asking countries to wait until 20% were double-vaccinated, globally.
Sir Andrew Pollard, head of the Oxford Vaccine Group, said on Tuesday (10 August) that herd immunity is "mythical" in relation to the Delta variant - as it still infects vaccinated individuals.
Physicians at University of California San Diego School of Medicine describe the first known case of a young, healthy adult who suffered brain inflammation after mild COVID-19 infection.
Lorna Green, Director of Enterprise and Growth, describes the role of the Innovation Agency and the AHSN Network across England and how health innovation is increasingly becoming integral to resolving the long-term challenges faced by the NHS.
According to a new study, fenofibrate, a drug used to treat abnormal levels of fatty substances in the blood, could reduce COVID-19 infection by up to 70%.
The Joint Committee on Vaccination and Immunisation (JCVI) has recommended that all 16 and 17-year-olds should receive their first dose of the Pfizer-BioNTech vaccine.
In a review of 91 studies across 17 countries, transgender and nonbinary youth were found to deal with "pervasive stigma and discrimination" in healthcare.
